Plataforma BIOBADASER III

Registro Español de Acontecimientos Adversos de Terapias Dirigidas en Enfermedades Reumáticas

Biobadaser Fase III

Evolution of Janus Kinase inhibitors prescriptions since 2015 in an international collaboration of RA registers (the JAK-pot study): effect of regulatory warnings

09/09/2026

Mongin D et al (JAK-POT)

Semin Arthritis Rheum

https://doi.org/10.1016/j.semarthrit.2026.152946

doi: 10.1016/j.semarthrit.2026.152946